Blue Trust Inc. Acquires 1,854 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Blue Trust Inc. raised its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC) by 84.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,048 shares of the health services provider’s stock after purchasing an additional 1,854 shares during the period. Blue Trust Inc.’s holdings in Teladoc Health were worth $40,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the business. Creative Planning boosted its holdings in Teladoc Health by 184.7% in the third quarter. Creative Planning now owns 64,125 shares of the health services provider’s stock valued at $589,000 after purchasing an additional 41,602 shares during the last quarter. Inspire Investing LLC acquired a new position in shares of Teladoc Health during the 3rd quarter worth about $409,000. Wedmont Private Capital acquired a new position in shares of Teladoc Health during the 3rd quarter worth about $120,000. CWM LLC raised its position in shares of Teladoc Health by 219.1% during the 3rd quarter. CWM LLC now owns 13,557 shares of the health services provider’s stock worth $124,000 after purchasing an additional 9,309 shares during the last quarter. Finally, SG Americas Securities LLC raised its holdings in Teladoc Health by 41.2% in the 3rd quarter. SG Americas Securities LLC now owns 76,891 shares of the health services provider’s stock valued at $706,000 after acquiring an additional 22,424 shares during the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on TDOC. Canaccord Genuity Group cut their price target on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating for the company in a report on Thursday, August 1st. DA Davidson cut their price target on shares of Teladoc Health from $12.00 to $8.00 and set a “neutral” rating on the stock in a research note on Thursday, August 1st. Royal Bank of Canada lifted their price target on shares of Teladoc Health from $9.00 to $10.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 9th. Oppenheimer dropped their price objective on shares of Teladoc Health from $21.00 to $17.00 and set an “outperform” rating on the stock in a research note on Thursday, August 1st. Finally, Stifel Nicolaus lowered their target price on shares of Teladoc Health from $16.00 to $9.00 and set a “hold” rating on the stock in a report on Thursday, August 1st. Fourteen investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $11.97.

Teladoc Health Stock Performance

Shares of TDOC stock opened at $9.22 on Friday. Teladoc Health, Inc. has a one year low of $6.76 and a one year high of $22.54. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.62 and a current ratio of 1.66. The company has a 50 day moving average price of $8.48 and a 200 day moving average price of $9.69. The firm has a market capitalization of $1.58 billion, a price-to-earnings ratio of -1.60 and a beta of 0.91.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.10. The company had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 9.40%. Sell-side analysts anticipate that Teladoc Health, Inc. will post -1.18 EPS for the current year.

Insider Activity

In other Teladoc Health news, CFO Mala Murthy sold 8,750 shares of the stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $62,650.00. Following the transaction, the chief financial officer now directly owns 85,767 shares in the company, valued at $614,091.72. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other Teladoc Health news, CFO Mala Murthy sold 8,750 shares of the stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $62,650.00. Following the sale, the chief financial officer now directly owns 85,767 shares of the company’s stock, valued at approximately $614,091.72. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Thomas Mckinley acquired 4,000 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average price of $7.69 per share, for a total transaction of $30,760.00. Following the completion of the transaction, the director now owns 39,077 shares in the company, valued at $300,502.13. The trade was a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders sold 36,588 shares of company stock worth $268,831. 0.95% of the stock is currently owned by company insiders.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.